Johanssen, Sarah

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification

Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 695

Radiotherapy in adrenocortical carcinoma

Polat, B., Fassnacht, M., Pfreundner, L., Guckenberger, M., Bratengeier, K., Johanssen, S., Kenn, W., Hahner, S., Allolio, B., & Flentje, M. (2009) · Cancer

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 189

Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial

Kroiss, M., Quinkler, M., Johanssen, S., van Erp, N. P., Lankheet, N., Pöllinger, A., Laubner, K., Strasburger, C. J., Hahner, S., Müller, H.-H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 175

Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma

Wortmann, S., Quinkler, M., Ritter, C., Kroiss, M., Johanssen, S., Hahner, S., Allolio, B., & Fassnacht, M. (2010) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsRenal cell carcinoma treatment

Cited by 133